Proactive Investors - Run By Investors For Investors

Investor Update: Tekcapital’s Belluscura set to receive FDA clearance

Top stories from the Proactive Investors UK newsroom.

Tekcapital (LON:TEK) says portfolio company Belluscura is set to receive US clearance next year for its patented portable oxygen concentrator. Belluscura’s also raised £725,000 in a funding round at 15p/share.

SDX Energy (LON:SDX) has made an oil discovery at its 50% owned Rabul-7 development well in Egypt.  It encountered close to 134 feet of net heavy oil pay and flowed at around 415 barrels daily over five days.

Clinigen (LON:CLIN) has been granted UK marketing authorisations for two melatonin products to treat jet-lag. The products were previously unlicensed and Clinigen expects to sell them directly to wholesalers or through its own supply and distribution chain.

Stagecoach says it has no intention of bidding for any more rail franchises when its last licence expires in November.  The bus and train group, which has taken legal action against the government over the franchise system, posted slightly higher profits in its latest year.

We-buy-any-car owner BCA Marketplace saw underlying profits rise by 8% and the number of cars sold top one million for a second year.  BCA is in talks over a takeover by private equity firm TDR.

Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full PROAC profile View Profile

Proactiveinvestors Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use